We work with institutional originators who need capital market solutions, and institutional investors who seek collateralised real asset exposure. Select your profile below.
SH operates as the specialist intermediary between institutional originators — banks, insurers, and portfolio holders with real asset exposure — and institutional investors seeking structured, collateralised returns. Each side has its own mandate, its own page.
Release regulatory capital through true-sale and synthetic securitisation of mortgage receivables. Achieve Significant Risk Transfer under Basel IV without disrupting the underlying borrower relationship.
Convert concentrated direct real estate exposure into rated, capital-efficient instruments under Solvency II. Retain economic exposure while reducing SCR capital consumption on real estate portfolios.
Capital market financing for real estate portfolios above EUR 20 million — where the bank market no longer offers competitive terms. Non-recourse, LMA-standard structures for holding companies, developers and family offices.
Access to senior and subordinated notes backed by European real estate and structured credit portfolios. Investment-grade and sub-investment-grade tranches structured to individual mandates, with full Article 7 reporting.